TABLE 2.
Characteristics of recorded interventions
| Parameter | Category | n | % |
|---|---|---|---|
| Number of recorded interventions | Number of observations | 130 | |
| Number of interventions | 21 | ||
|
| |||
| BNF* group of drug involved | Malignant diseases & immunosupression | 27 / 29† | 93 % |
| • Antimetabolites | 6 / 29† | 21 % | |
| • Anthracyclines & other cytotoxic antibiotics | 5 / 29† | 17 % | |
| • Vinca alkaloids & etoposide | 4 / 29† | 14 % | |
| • Other antineoplastic drugs: Taxanes | 4 / 29† | 14 % | |
| • Other antineoplastic drugs | 8 / 29† | 28 % | |
| Drugs outside malignant disease & immunosupression group | 2 / 29† | 7 % | |
|
| |||
| Identified drug related problem | Drug and therapy | 8 / 21 | 38 % |
| Clerical | 7 / 21 | 33 % | |
| Dose, frequency and duration | 4 / 21 | 19 % | |
| Administration and formulation | 2 / 21 | 10 % | |
|
| |||
| Contacted healthcare professional | Clinician | 13 / 21 | 62 % |
| Nurse | 2 / 21 | 10 % | |
| None | 6 / 21 | 29 % | |
|
| |||
| Implementation of the intervention | Implemented | 18 / 21 | 86 % |
| Implemented, with amendments | 1 / 21 | 5 % | |
| Not implemented | 2 / 21 | 10 % | |
*
BNF stands for British National Formulary
†
one intervention could involve more than one drug